Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir™: a Potential Treatment for Covid-19
December 16, 2021 12:25 ET
|
Todos Medical Ltd.
Webinar to be held on December 22nd @ 12pm EST NLC Pharma and Todos agree to extend closing date for formation of 3CL Sciences to December 31, 2021 while the companies complete legal due diligence ...
Todos Medical Enters 90-Day Extension of Agreement with Convertible Note Holders on Moratorium on Conversions of Convertible Notes
December 13, 2021 07:30 ET
|
Todos Medical Ltd.
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Dec. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...
Todos Medical Interview and Presentation on Benzinga's All Access Conference Live December 14th at 10:20 AM EST
December 10, 2021 12:29 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces 2 New COVID-19 PCR Testing Reference Lab Agreements for CLIA/CAP Lab Provista Diagnostics
December 07, 2021 09:19 ET
|
Todos Medical Ltd.
Combined testing from two contracts averages 1,000 PCR samples per dayTesting potential for the two contracts could ramp up to 5,000 PCR samples per day New York, NY, Alpharetta, GA and Tel...
Todos Medical to Present at Upcoming Emerging Growth Conference
December 06, 2021 15:14 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation
December 02, 2021 06:00 ET
|
Todos Medical Ltd.
Dr. Jules Mitchel now leading preparation for data lock and statistical analysisBusiness update call Today at 4:30PM EST New York, NY, and Tel Aviv, ISRAEL, Dec. 02, 2021 (GLOBE NEWSWIRE) -- via...
Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST
December 01, 2021 16:05 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
November 30, 2021 10:35 ET
|
Todos Medical Ltd.
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IPDr. Dorit...
Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant
November 30, 2021 08:39 ET
|
Todos Medical Ltd.
Provista to also utilize Osang’s High-Capacity Reflex Variant PCR Detection Kit that has been confirmed to identify the Omicron variant New York, NY, and Tel Aviv, ISRAEL, Nov. 30, 2021 (GLOBE...
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
November 29, 2021 09:08 ET
|
Todos Medical Ltd.
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP Dr....